Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
1.03
Dollar change
-0.01
Percentage change
-0.96
%
Index- P/E- EPS (ttm)-0.45 Insider Own15.52% Shs Outstand74.75M Perf Week-1.90%
Market Cap77.37M Forward P/E- EPS next Y-0.45 Insider Trans0.52% Shs Float64.07M Perf Month-4.63%
Income-31.88M PEG- EPS next Q-0.10 Inst Own15.97% Short Float2.37% Perf Quarter-2.83%
Sales7.70M P/S10.05 EPS this Y11.86% Inst Trans-18.74% Short Ratio2.07 Perf Half Y-15.57%
Book/sh-0.47 P/B- EPS next Y3.67% ROA-100.27% Short Interest1.52M Perf Year-11.21%
Cash/sh0.31 P/C3.28 EPS next 5Y- ROE-1310.02% 52W Range0.92 - 2.12 Perf YTD-11.97%
Dividend Est.- P/FCF- EPS past 5Y27.88% ROI-215.23% 52W High-51.42% Beta2.20
Dividend TTM- Quick Ratio4.49 Sales past 5Y1621.13% Gross Margin97.83% 52W Low11.96% ATR (14)0.06
Dividend Ex-Date- Current Ratio4.49 EPS Y/Y TTM26.05% Oper. Margin-319.98% RSI (14)44.14 Volatility6.07% 5.75%
Employees30 Debt/Eq- Sales Y/Y TTM248.39% Profit Margin-413.83% Recom1.00 Target Price6.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q31.17% Payout- Rel Volume0.53 Prev Close1.04
Sales Surprise698.46% EPS Surprise19.55% Sales Q/Q20.84% EarningsNov 12 AMC Avg Volume736.15K Price1.03
SMA20-2.83% SMA50-9.79% SMA200-17.00% Trades Volume391,615 Change-0.96%
Date Action Analyst Rating Change Price Target Change
Aug-21-24Initiated Chardan Capital Markets Buy $6
Jun-25-24Initiated Oppenheimer Outperform $5
Dec-15-21Resumed Wedbush Outperform $19 → $9
Jul-29-21Initiated H.C. Wainwright Buy $10
May-13-20Initiated ROTH Capital Buy $8
Aug-09-19Downgrade Needham Buy → Hold
Nov-05-18Downgrade Stifel Buy → Hold
Nov-05-18Downgrade JP Morgan Overweight → Underweight
Nov-05-18Downgrade Cowen Outperform → Market Perform
Mar-06-18Reiterated Needham Buy $18 → $22
Nov-25-24 07:05AM
Nov-15-24 12:00PM
Nov-13-24 02:17AM
Nov-12-24 06:05PM
04:05PM
07:23AM Loading…
Nov-11-24 07:23AM
Nov-08-24 03:56AM
Nov-07-24 09:05AM
Nov-06-24 07:05AM
Nov-04-24 07:05AM
Oct-31-24 07:05AM
Oct-22-24 07:05AM
Oct-10-24 08:57AM
Oct-09-24 10:22AM
06:30AM
07:05AM Loading…
Aug-27-24 07:05AM
Aug-15-24 09:35AM
Aug-12-24 05:25PM
04:05PM
Aug-08-24 07:05AM
Aug-05-24 10:00AM
Aug-01-24 07:05AM
Jul-29-24 04:05PM
Jul-22-24 12:00PM
Jul-11-24 07:05AM
Jun-27-24 07:05AM
Jun-12-24 07:05AM
May-21-24 07:05AM
May-13-24 08:20AM
May-10-24 02:15PM
11:56AM Loading…
11:56AM
May-09-24 06:55PM
04:05PM
May-08-24 04:15PM
Apr-30-24 07:05AM
Apr-16-24 07:05AM
Apr-02-24 07:05AM
Mar-18-24 07:05AM
Mar-13-24 08:30AM
06:38AM
Mar-12-24 05:35PM
04:05PM
Mar-06-24 02:25PM
Feb-29-24 07:05AM
Feb-25-24 01:37PM
Feb-07-24 08:00AM
Dec-14-23 07:05AM
Nov-14-23 09:11AM
Nov-13-23 04:05PM
Nov-08-23 07:05AM
Nov-07-23 04:20PM
Nov-03-23 12:00PM
Nov-02-23 07:05AM
Nov-01-23 07:05AM
Oct-31-23 07:05AM
Oct-26-23 12:24AM
Oct-16-23 07:05AM
Oct-04-23 09:00AM
Oct-03-23 04:35PM
Sep-19-23 07:05AM
Aug-14-23 04:05PM
Aug-02-23 04:30PM
Aug-01-23 07:05AM
Jul-31-23 07:05AM
Jul-20-23 07:05AM
Jul-11-23 04:05PM
Jul-10-23 07:05AM
Jun-29-23 09:50AM
Jun-01-23 07:05AM
May-11-23 08:25AM
07:05AM
May-09-23 04:30PM
May-02-23 07:05AM
Apr-27-23 07:05AM
Apr-18-23 07:05AM
Apr-12-23 07:05AM
Apr-09-23 09:42AM
Apr-05-23 07:05AM
Mar-11-23 03:14AM
Mar-09-23 06:35PM
04:05PM
Feb-23-23 07:05AM
Feb-21-23 07:05AM
Feb-07-23 07:05AM
Feb-06-23 07:30AM
Feb-02-23 01:18PM
07:05AM
Dec-22-22 09:52AM
05:05AM
Nov-22-22 07:05AM
Nov-11-22 05:26AM
Nov-10-22 01:24PM
07:05AM
Nov-09-22 09:05AM
07:15AM
07:05AM
Nov-08-22 04:05PM
Nov-02-22 07:05AM
Oct-31-22 08:52AM
Oct-17-22 11:27AM
Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chong Ngai Hang VictorChief Medical OfficerNov 01 '24Buy1.0036,50036,500100,000Nov 04 04:15 PM
Chong Ngai Hang VictorChief Medical OfficerJun 24 '24Buy1.0623,50024,91063,500Jun 24 04:38 PM
YERXA BENJAMIN RDirectorMay 15 '24Buy1.317,81310,23517,957May 15 05:28 PM
Gibney Anthony SDirectorApr 18 '24Buy1.3093,290121,277100,000Apr 19 09:45 AM
Gibney Anthony SDirectorApr 17 '24Buy1.256,7108,3886,710Apr 19 09:45 AM
Chong Ngai Hang VictorCHIEF MEDICAL OFFICERMar 20 '24Buy1.6030,00048,00030,000Mar 20 04:30 PM
WHITMORE BRADFORD T10% OwnerFeb 07 '24Buy1.35444,444599,9994,495,034Feb 09 01:00 PM
LASEZKAY GEORGE MCEOJan 19 '24Sale1.2718,00022,860466,577Jan 19 06:26 PM
Deignan Charles A.Chief Financial OfficerJan 19 '24Sale1.2812,90016,512384,662Jan 19 06:25 PM